Biological variation in urinary excretion of pyridinium crosslinks: Recommendations for the optimum specimen

Annals of Clinical Biochemistry

Volumn 33, Issue 1, 1996, Pages 36-42

  Panteghini, M ^a   Pagani, F ^a  

^a SPEDALI CIVILI   (Italy)

Author keywords

Analysis of variance; Bone resorption; Reference values; Reproducibility of results

Indexed keywords

CREATININE; PYRIDINIUM DERIVATIVE;

ADULT; ARTICLE; CREATININE URINE LEVEL; CROSS LINKING; FEMALE; GENDER; HUMAN; MALE; NORMAL HUMAN; OSTEOLYSIS; PRIORITY JOURNAL; REPRODUCIBILITY; RISK ASSESSMENT; STATISTICAL ANALYSIS; URINARY EXCRETION;

EID: 0030058624     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1177/000456329603300105     Document Type: Article

References (28)

1. Eyre D. Collagen cross-linking amino acids. Meth Enzymol 1987; 144: 115-39
2. Pyridinium crosslinks as markers of bone resorption. Lancet 1992; 340: 278-9
3. Uebelhart D, Gineyts E, Chapuy MC, Delmas PD. Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease. Bone Min 1990; 8: 87-96
4. Robins SP, Black D, Paterson CR, Reid DM, Duncan A, Seibel MJ. Evaluation of urinary hydroxypyridinium crosslink measurements as resorption markers in metabolic bone diseases. Eur J Clin Invest 1991; 21: 310-15
5. Bettica P, Moro L, Robins SP, Taylor AK, Talbot J, Singer FR, et al. Bone-resorption markers galactosyl hydroxylysine, pyridinium crosslinks, and hydroxyproline compared. Clin Chem 1992; 38: 2313-18
6. Delmas PD, Gineyts E, Bertholin A, Garnero P, Marchand F. Immunoassay of pyridinoline crosslink excretion in normal adults and in Paget's disease. J Bone Min Res 1993; 8: 643-8
7. Seibel MJ, Gartenberg F, Silverberg SJ, Ratcliffe A, Robins SP, Bilezikian JP. Urinary hydroxypyridinium cross-links of collagen in primary hyperparathyroidism. J Clin Endocrinol Metab 1992; 74: 481-6
8. McLaren AM, Hordon LD, Bird HA, Robins SP. Urinary excretion of pyridinium crosslinks of collagen in patients with osteoporosis and the effects of bone fracture. Ann Rheum Dis 1992; 51: 648-51
9. Paterson CR, Robins SP, Horobin JM, Preece PE, Cuschieri A. Pyridinium crosslinks as markers of bone resorption in patients with breast cancer. Br J Cancer 1991; 64: 884-6
10. Lipton A, Demers L, Daniloff Y, Curley E, Hamilton C, Harvey H, et al. Increased urinary excretion of pyridinium cross-links in cancer patients. Clin Chem 1993; 39: 614-18
11. Schlemmer A, Hassager C, Jensen SB, Christiansen C. Marked diurnal variation in urinary excretion of pyridinium cross-links in premenopausal women. J Clin Endocrinol Metab 1992; 74: 476-80
12. Pagani F, Panteghini M. Diurnal rhythm in urinary excretion of pyridinium crosslinks. Clin Chem 1994; 40: 952-3
13. Howey JEA, Browning MCK, Fraser CG. Selecting the optimum specimen for assessing slight albuminuria, and a strategy for clinical investigation: novel uses of data on biological variation. Clin Chem 1987; 33: 2034-8
14. Fraser CG, Harris EK. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 1989; 27: 409-37
15. Fraser CG, Hyltoft Petersen P. The importance of imprecision. Ann Clin Biochem 1991; 28: 207-11
16. Seyedin SM, Kung VT, Daniloff YN, Hesley RP, Gomez B, Nielsen LA, et al. Immunoassay for urinary pyridinoline: the new marker of bone resorption. J Bone Min Res 1993; 8: 635-41
17. Young DS, Harris EK, Cotlove E. Biological and analytic components of variation in long-term studies of serum constituents in normal subjects. IV. Results of a study designed to eliminate long-term analytic deviations. Clin Chem 1971; 17: 403-10
18. Fraser CG, Hyltoft Petersen P, Ricòs C, Haeckel R. Proposed quality specifications for the imprecision and inaccuracy of analytical systems for clinical chemistry. Eur J Clin Chem Clin Biochem 1992; 30: 311-17
19. Harris EK. Effects of intra- and inter-individual variation on the appropriate use of normal range. Clin Chem 1974; 20: 1535-42
20. Fraser CG, Fogarty Y. Interpreting laboratory results. BMJ 1989; 298: 1659-60
21. Black D, Marabani M, Sturrock RD, Robins SP. Urinary excretion of the hydroxypyridinium cross links of collagen in patients with rheumatoid arthritis. Ann Rheum Dis 1989; 48: 641-4
22. Beardsworth LJ, Eyre DR, Dickson IR. Changes with age in the urinary excretion of lysyl- and hydroxylysylpyridinoline, two new markers of bone collagen turnover. J Bone Min Res 1990; 5: 671-6
23. Kollerup G, Thamsborg G, Bhatia H, Helmer Sorensen O. Quantitation of urinary hydroxypyridinium cross-links from collagen by high-performance liquid chromatography. Scand J Clin Lab Invest 1992; 52: 657-62
24. Black D, Duncan A, Robins SP. Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography. Anal Biochem 1988; 169: 197-203
25. Body JJ, Delmas PD. Urinary pyridinium cross-links as markers of bone resorption in tumor-associated hypercalcemia. J Clin Endocrinol Metab 1992; 74: 471-5
26. Seibel MJ, Duncan A, Robins SP. Urinary hydroxy-pyridinium crosslinks provide indices of cartilage and bone involvement in arthritic diseases. J Rheumatol 1989; 16: 964-70
27. Fraser CG. The application of theoretical goals based on biological variation data in proficiency testing. Arch Pathol Lab Med 1988; 112: 404-15
28. Fraser CG. Biological variation in clinical chemistry. An update: collated data, 1988-1991. Arch Pathol Lab Med 1992; 116: 916-23